References
- Migliorini P., Baldini C., Rocchi V., Bombardieri S. Anti‐Sm and anti‐RNP antibodies. Autoimmunity 2005; 38: 47–54
- Miyawaki S., Asanuma H., Nishiyama S., Yoshinaga Y. Clinical and serological heterogeneity in patients with anticentromere antibodies. J Rheumatol 2005; 32: 1488–94
- Kuwana M., Kaburaki J., Okano Y., Tojo T., Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 1994; 37: 75–83
- Jacobsen S., Halberg P., Ullman S., Van Venrooij W. J., Hoier‐Madsen M., Wiik A., et al. Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Br J Rheumatol 1998; 37: 39–45
- Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7
- LeRoy E. C., Trojanowska M., Smith E. A. The pathogenesis of scleroderma (systemic sclerosis, SSc). Clin Exp Rheumatol 1991; 9: 173–7
- Bohan A., Peter J. B. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292: 403–7
- Nakano T., Inoue K., Hirohara J., Arita S., Higuchi K., Omata M., et al. Long‐term prognosis of primary biliary cirrhosis (PBC) in Japan and analysis of the factors of stage progression in asymptomatic PBC (a‐PBC). Hepatol Res 2002; 22: 250–60
- Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H. M., Alexander E. L., Carsons S. E., et al. European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 2002; 61: 554–8
- Kasukawa R., Tojo T., Miyawaki S. Preliminary diagnostic criteria for classification of mixed connective tissue disease. Mixed connective tissue disease and antinuclear antibodies, R Kasukawa, G. C Sharp. Elsevier, Amsterdam 1987; 41–7
- Weening J. J., D'Agati V. D., Schwartz M. M., Seshan S. V., Alpers C. E., Appel G. B., et al. International Society of Nephrology Working Group on the Classification of Lupus Nephritis; Renal Pathology Society Working Group on the Classification of Lupus Nephritis. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65: 521–30
- Burdt M. A., Hoffman R. W., Deutscher S. L., Wang G. S., Johnson J. C., Sharp G. C. Long‐term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 1999; 42: 899–909
- Dick T., Mierau R., Bartz‐Bazzanella P., Alavi M., Stoyanova‐Scholz M., Kindler J., et al. Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis. Ann Rheum Dis 2002; 61: 121–7
- Steen V. D. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005; 35: 35–42
- Kurien B. T., Scofield R. H. Autoantibody determination in the diagnosis of systemic lupus erythematosus. Scand J Immunol 2006; 64: 227–35
- Nakano M., Ohuchi Y., Hasegawa H., Kuroda T., Ito S., Gejyo F. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus. J Rheumatol 2000; 27: 1403–7
- Respaldiza N., Wichmann I., Ocaña C., Garcia‐Hernandez F. J., Castillo M. J., Magariño M. I., et al. Anti‐centromere antibodies in patients with systemic lupus erythematosus. Scand J Rheumatol 2006; 35: 290–4
- Lundberg I., Hedfors E. Clinical course of patients with anti‐RNP antibodies. A prospective study of 32 patients. J Rheumatol 1991; 18: 1511–19
- Frandsen P. B., Kriegbaum N. J., Ullman S., Høier‐Madsen M., Wiik A., Halberg P. Follow‐up of 151 patients with high‐titre U1RNP antibodies. Clin Rheumatol 1996; 15: 254–60
- Greidinger E. L., Zang Y., Jaimes K., Hogenmiller S., Nassiri M., Bejarano P., et al. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen. Arthritis Rheum 2006; 54: 661–9
- Nakamura M., Kondo H., Mori T., Komori A., Matsuyama M., Ito M., et al. Anti‐gp210 and anti‐centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 2007; 45: 118–27